Cameron John Reynolds - 24 Jul 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Cameron John Reynolds
Issuer symbol
VNRX
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
25 Jul 2025, 16:01:15 UTC
Previous filing
16 Jun 2025
Next filing
06 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reynolds Cameron John President and CEO, Director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON /s/ Cameron John Reynolds 25 Jul 2025 0001340610

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +200,000 +8.6% $0.000000 2,531,722 24 Jul 2025 Direct F1
holding VNRX Common Stock 1,007,718 24 Jul 2025 By Concord International, Inc. F2
holding VNRX Common Stock 34,076 24 Jul 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received 200,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $2.50 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to July 24, 2028, which date shall be no earlier than July 24, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.